Hosted on MSN
Umbilical cord blood transplant with pooled stem cell product shows 96% survival and no GVHD in leukemia patients
A new way of using umbilical cord blood for treating blood diseases could make the treatment more accessible to patients who need a stem cell transplant. A Phase II clinical trial of patients ...
While bulk sequencing quickly became the preferred method, scRNA-seq has increased in popularity in the last decade. In 2015, just 6 % of RNA-seq papers used single-cell methodologies. By 2025, the ...
A phase 2 study published in the Journal of Clinical Oncology shows that a stem cell product called dilanubicel safely enabled umbilical cord blood transplants in 28 patients SEATTLE — April, 27, 2026 ...
SEATTLE — April, 27, 2026 — A new way of using umbilical cord blood for treating blood diseases could make the treatment more accessible to patients who need a stem cell transplant. A phase 2 clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results